With the U.S. buying up most of Gilead’s stock of COVID-19 drug remdesivir, what hope is there for other countries who wish to treat people with COVID-19? An expert surveys the pharma production situation. The U.S. has leveraged its economic might to obtain almost all of the global stocks of the COVID-19 treatment drug remdesivir.